Quick Answer
Decoy Therapeutics Inc. reported Common Stock Shares Outstanding of 1.44 million shares for the year ending 2024.
- Decoy Therapeutics Inc. showed an increase of +192.7% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 21, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2014 to 2024), Decoy Therapeutics Inc.'s Common Stock Shares Outstanding has declined by 35.0%.
- Historical annual values: Fiscal year 2024: 1.44 million shares | Fiscal year 2023: 492,304 shares | Fiscal year 2022: 2.26 million shares | Fiscal year 2021: 1.81 million shares | Fiscal year 2020: 23.81 million shares | Fiscal year 2019: 4.51 million shares | Fiscal year 2018: 2.03 million shares | Fiscal year 2017: 17.80 million shares | Fiscal year 2016: 16.77 million shares | Fiscal year 2015: 15.74 million shares | Fiscal year 2014: 2.22 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: